<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT2016081229311N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2016-08-24</date_registration>
      <primary_sponsor>Tek Grup</primary_sponsor>
      <public_title>The Effect of Neiguan Point (p6) Acupressure with Wristband on Postoperative Nausea, Vomiting, and Comfort Level: A Randomized Controlled Study</public_title>
      <acronym></acronym>
      <scientific_title>The Effect of Neiguan Point (p6) Acupressure with Wristband on Postoperative Nausea, Vomiting, and Comfort Level: A Randomized Controlled Study</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2013-02-02</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>97</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/23595</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Other design features: Objective and design of the study&#13;
The study was designed as a randomized-controlled experimental study to determine the effect of wrist P6 acupuncture point acupressure application with wristband on nausea, vomiting, and comfort level at the postoperative period. The following hypotheses were tested:&#13;
H1A: Wrist P6 (Neiguan) acupuncture point acupressure application with wristband is effective as pharmacological methods in prevention of postoperative nausea.&#13;
H1B: Wrist P6 acupuncture point acupressure application with wristband is effective as pharmacological methods in prevention of postoperative vomiting.&#13;
H1C: Wrist P6 acupuncture point acupressure application with wristband enhances patient comfort.&#13;
&#13;
Study variables: Wrist P6 acupuncture point acupressure application with wristband is the independent variable of the study. Dependent variables are nausea, vomiting, and comfort level.&#13;
Study population and sampling method&#13;
The study population consists of patients who underwent a gynecological surgery other than Caesarian section (A, B, and C group operations) in an obstetrics hospital within the province of Bursa in Turkey. The population size was determined by reviewing the year 2011’s data, which showed that a total of 4,946 operations (A, B and C group) had been performed in the hospital that the study was conducted. A review of the literature showed that the incidence of nausea following gynecological operations varied between 58-77% (Kaya et al., 2010). When the population size was 4,946 and incidence of nausea was as 58%, the study sample size was calculated to be 92, which was within 5% significance level and 10% error margin. Accounting for possible issues that may occur during data collection period, an additional 8 patients were added to the sample size; thus, the final sample size was determined as 100. However, in the experimental group, 2 patients received anti-emetics, and one patient was discharged earlier than planned. Therefore, 3 patients from the experimental group were excluded from the study. In the end, there were 47 patients in experimental group and 50 patients in control group.&#13;
&#13;
Data collection tools &#13;
&#13;
Patient Information Form: This form contains personal information such as age, height, weight, health insurance, use of antiemetic drug during the last 24 hours, presence of any disease, or complaints, and also type and duration of anesthesia.&#13;
&#13;
State - Trait Anxiety Inventory (STAI):  It was developed by Spielberger et al. (1970) for assessment of state and trait anxiety levels. Öner and Le Compte (1985) performed reliability and validity studies of this scale in Turkish population. The scale comprises two separate sections made of a total of 40 items, and was designed based on two factor anxiety concept. The first 20 items were used to assess state anxiety level, whereas the latter 20 items were for assessment of trait anxiety levels. Possible scores from both subscales range from 20 to 80 (Alacacıoğlu et al., 2007).  Higher scores suggest a greater level of anxiety. Data for STAI was obtained from the experimental and control groups at the hospital admission.&#13;
&#13;
Nausea and Vomiting Follow-up Form:  It was used to document intensity of nausea (0-10 point visual analog scale) and presence of vomiting (1: present, 2: absent) at the following intervals postoperatively: 0-2, 2-6, 6-12, 12-24 and 24-48 hours. Thus, the group that used wristband (experimental group) and the group that received anti-emetics according to the institution's protocol/physician order (control group) were compared in terms of intensity of nausea and presence of vomiting.&#13;
&#13;
Perianesthesia Comfort Questionnaire (PCQ): It was developed by Kolcaba and Wilson (2002), and validity and reliability study for Turkish version was conducted by Üstündağ and Eti Aslan (2010). The questionnaire was comprised of 24 items questioning self-comprehension and feelings that reflected general thought process before and after the surgical intervention. The total score was divided by the number of items to determine the mean value, and the result was expressed in a 6-point Likert scale. Lower scores indicated bad comfort, while higher scores indicated good comfort. Data for PCQ was obtained from both the experimental and control groups at the 12-hours post-operation.&#13;
&#13;
General Comfort Questionnaire (GCQ): It was developed by Kolcaba (1992), and validity and reliability study for Turkish version was conducted by Kuğuoğlu and Karabacak (2004). GCQ was designed based on the taxonomic concept, which included three types of comfort and four contexts that constitute the theoretical components of comfort. It was used to determine patient demands, and to assess achievement of desired comfort level that was expected after nursing interventions aimed at providing comfort. Maximum achievable score was 192, and minimum score was 48. Lower scores indicate lack of comfort, and higher scores indicate high comfort (Kuğuoğlu ve Karabacak 2008). Data for GCQ was obtained from both experimental and control group patients at the time of their discharge from hospital.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Postoperative nausea and vomiting.</hc_freetext>
      <i_freetext>By screening the list of patients to be operated, those patients who met study inclusion criteria were determined. Those who were selected for enrollment in the study were informed about nausea occurring at the postoperative period, and about acupressure or antiemetic application that were used to prevent it. They were given written and verbal information about the study procedure. Individuals volunteering to participate in the study signed the Informed Voluntary Consent Form. Enrolled patients were randomly divided into patient and control groups by drawing lots. Consequently, the Patient Information Form and State-Trait Anxiety Inventory were filled; and groups were evaluated for presence of any difference.&#13;
At postoperative period; Experimental Group: Within the first 12 hours after the operation, acupressure with wristband was applied to patient group. Anesthesiologists were informed of these patients group to make sure that they were not administered anti emetics intra-operatively. Intensity of nausea and presence of vomiting at the postoperative period were documented on the Nausea and Vomiting Follow-up Form. In case intensity of nausea did not decrease or vomiting persisted, then patient’s physician was informed, and anti-emetics ordered by the physician were administered to the patient. In such a case, the patient was excluded from the experimental group. Two patients were excluded from the experimental group due to these reasons. Thus, any harm to the patient was prevented, and all arrangements required for patients to have optimum benefit from care-treatment interventions were provided. &#13;
Control Group: The protocol in the hospital where the study was conducted is that all patients undergoing surgery (including A, B, and C group) are administered anti-emetics intraoperatively. Therefore, all patients in the control group received intra-operative anti-emetics. Additionally, patients in the control group received anti-emetics within the first 12 hours after operation, as appropriate to the clinical routine (ordered by the physician). Intensity of nausea and presence of vomiting were documented on the Nausea and Vomiting Follow-up Form. After 12 hours from the operation, PCQ was applied to both the experimental and control groups, in order to determine comfort levels before and after operation. Additionally, the comfort level for each person at the time of discharge was assessed with GCQ in both groups..</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Nurten Kaya</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Demirkapı Cad. Karabal Sk. Bakırköy Ruh ve Sinir Hastalıkları Hastanesi Bahçesi İçi</address>
        <city>Istanbul</city>
        <country1>Turkey</country1>
        <zip>34740</zip>
        <telephone>00902124141500</telephone>
        <email>nurka@istanbul.edu.tr, nurtenkaya66@gmail.com, nurtenkaya66@hotmail.com</email>
        <affiliation>Istanbul University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Nurten Kaya</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Demirkapı Cad. Karabal Sk. Bakırköy Ruh ve Sinir Hastalıkları Hastanesi Bahçesi İçi</address>
        <city>Istanbul</city>
        <country1>Turkey</country1>
        <zip>34740</zip>
        <telephone>00902124141500</telephone>
        <email>nurka@istanbul.edu.tr, nurtenkaya66@gmail.com, nurtenkaya66@hotmail.com</email>
        <affiliation>Istanbul University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Turkey</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age between 18-65 years, Patient underwent gynecological operation;  Operation was performed under general anesthesia; The patient had no cognitive; sensory or verbal communication issues; Patient volunteered to participate in the study.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>64 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>Z48.9</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Surgical follow-up care, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>By screening the list of patients to be operated, those patients who met study inclusion criteria were determined. Those who were selected for enrollment in the study were informed about nausea occurring at the postoperative period, and about acupressure or antiemetic application that were used to prevent it. They were given written and verbal information about the study procedure. Individuals volunteering to participate in the study signed the Informed Voluntary Consent Form. Enrolled patients were randomly divided into patient and control groups by drawing lots. Consequently, the Patient Information Form and State-Trait Anxiety Inventory were filled; and groups were evaluated for presence of any difference.&#13;
At postoperative period; Experimental Group: Within the first 12 hours after the operation, acupressure with wristband was applied to patient group. Anesthesiologists were informed of these patients group to make sure that they were not administered anti emetics intra-operatively. Intensity of nausea and presence of vomiting at the postoperative period were documented on the Nausea and Vomiting Follow-up Form. In case intensity of nausea did not decrease or vomiting persisted, then patient’s physician was informed, and anti-emetics ordered by the physician were administered to the patient. In such a case, the patient was excluded from the experimental group. Two patients were excluded from the experimental group due to these reasons. Thus, any harm to the patient was prevented, and all arrangements required for patients to have optimum benefit from care-treatment interventions were provided. &#13;
Control Group: The protocol in the hospital where the study was conducted is that all patients undergoing surgery (including A, B, and C group) are administered anti-emetics intraoperatively. Therefore, all patients in the control group received intra-operative anti-emetics. Additionally, patients in the control group received anti-emetics within the first 12 hours after operation, as appropriate to the clinical routine (ordered by the physician). Intensity of nausea and presence of vomiting were documented on the Nausea and Vomiting Follow-up Form. After 12 hours from the operation, PCQ was applied to both the experimental and control groups, in order to determine comfort levels before and after operation. Additionally, the comfort level for each person at the time of discharge was assessed with GCQ in both groups.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Nausea, vomiting, and comfort level at the postoperative period. Timepoint: Postoperative period. Method of measurement: This was a single-center, randomized-controlled experimental study conducted in the Turkey.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Nausea, vomiting, and comfort level at the postoperative period. Timepoint: Postoperative period. Method of measurement: This was a single-center, randomized-controlled experimental study conducted in the Turkey.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tek Grup</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2013-02-01</approval_date>
        <contact_name>Uludağ University Faculty of Medicine Clinical Research Ethics Committee</contact_name>
        <contact_address>Uludag University Medical Faculty Deanery, 16059, Nilüfer/BURSA Bursa  Turkey</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
